Avencia Sánchez-Mejías invited to speak at the first CRISPR Medicine Conference in Europe

CRISPR Medicine Conference 2024

Dr. Avencia Sánchez-Mejías, CEO and Co-Founder of Integra Therapeutics, will speak at the first CRISPR Medicine Conference held April 23 to 25 in Copenhagen, Denmark. The conference will bring together over 400 delegates from the European CRISPR medicine and genomic medicine community for two days of learning, networking and stimulating discussions. The program includes talks […]